Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients

Efficacy and Safety of Circular Cyclocoagulation Using High Intensity Focused Ultrasound With EYEOP1 Device in Glaucoma Patients. Prospective Multicenter Clinical Trial.

The aim of the study is to evaluate the effectiveness and the safety of the cyclocoagulation using HIFU in glaucoma patients

Inclusion Criteria:

• Primary Open-angle glaucoma included pseudo-exfoliative glaucoma and pigmentary glaucoma
• IOP > 21 mm Hg on glaucoma medications, and indicated for filtering glaucoma surgery
• Patient must be aged 18 years and more
• No previous cyclophotocoagulation procedure in the eye
• No previous laser treatment in the eye during the 3 months before HIFU procedure

Exclusion Criteria:

• History of previous glaucoma surgery with implantation of glaucoma drainage device in the study eye
• History of ocular or retrobulbar tumor
• retinal detachment, choroidal hemorrhage or detachment
• Ocular infectious diseasee within 14 days before HIFU procedure